 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $46.42 | 0.33 (0.72%)
| | NVS | $59.92 | 1.94 (3.35%)
| | SNY | $36.2 | 0.19 (0.53%)
| | GSK | $47.67 | -0.99 (-2.03%)
|
|
|
|
|
|
 |
 Current Topics |
 |
|
Intravenous Iron in the Management of Chemotherapy-Induced Anemia: An Update from ASCO 2007 - CME
Michael Auerbach, MD, Georgetown University School of Medicine, Baltimore, MD Advances in the Treatment of Myelosuppression and Anemia
John Glaspy, MD, Director of Clinical Research Unit Shared Resource, UCLA Medical Center. Classifying and Managing Chemotherapy-Induced Anemia
Charles H. Weaver, MD, and Jenny Maxon, RN. ASH 2007: Supportive Care and Hematologic Malignancies - CME Advances in the Treatment of Myelosuppression and Anemia - CME Classifying and Managing Chemotherapy-Induced Anemia - CME Anemia and the Use of Hematopoietic Growth Factors - CME The Role of Erythropoietic Agents in Managing the Anemia of Cancer Anemia and Gastrointestinal Cancer: Updates from ASCO GI 2007 Main - Refractory Anemia with Excess Blasts in Transformation Main - Refractory Anemia with Excess Blasts
|
|
|
 |
|
 |
|
 Conference Coverage |
|
|
Latest Anemia News |
|
|
Newsletters |
|
|
 |
Register in our member center today to receive a monthly newsletter with clinical news, conference coverage, and current topic updates.
Learn More »
|
|
|
|
|
|
|
 Information by Cancer Type |
|
|
|
|
|
|
|
|
|
|
Patient Home
